GlassScriptPhysician profile
Matthew Michael Dambrosio
NPI 1568966141
$37,967.27
in general payments reported to CMS, 2019-2025
8 companies · $33K in 2025
The $33K reported for 2025 was more than what 83% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $401 · 2024: $4,713 · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Travel and Lodging: $7,834 · Food and Beverage: $3,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,950.00 |
| Travel and Lodging | $7,833.64 |
| Food and Beverage | $3,183.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vb Spine LLC | $27,044.30 | 2025 | Cascadia Interbody System, Everest Spinal System |
| Stryker Corporation | $7,773.82 | 2024-2025 | Everest Spinal System, Aero-Ll, Capri Corpectomy Cage System |
| Medtronic, INC. | $1,742.82 | 2023-2025 | Mazor X System, Intellis Adaptivestim, Infinity Occipitocervical Upper Thoracic System |
| Globus Medical, INC. | $878.58 | 2024-2025 | Excelsius Gps, Xlif, Reline |
| Depuy Synthes Products, INC. | $324.57 | 2025 | Velys |
| Providence Medical Technology, INC. | $90.86 | 2025 | |
| Depuy Synthes Sales INC. | $58.11 | 2025 | Spine & Trauma 3d Navigation |
| Cerapedics INC. | $54.21 | 2024 | I-Factor Peptide Enhanced Bone Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Dambrosio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.